6mer seed toxicity and AIDS
6mer seed toxicity and AIDS
批准号:
10132980
负责人:
Marcus E. Peter
金额:
$23.85万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-25 至 2023-02-28
关键词:
3&apos Untranslated RegionsAcquired Immunodeficiency SyndromeAntioxidantsApoptosisAutomobile DrivingAutophagocytosisBasic ScienceBiogenesisCD4 Positive T LymphocytesCell DeathCell Death InductionCell LineCellsCessation of lifeCodeComplexDataData SetDicer EnzymeDown-RegulationGenerationsGenesGoalsHIVHIV InfectionsHIV-1HybridsInfectionKnock-outLigationMediatingMessenger RNAMicroRNAsMitoticMolecularNecrosisPathway interactionsPharmacotherapyProductionProteinsProvirusesRNARNA InterferenceRNA-Induced Silencing ComplexReactive Oxygen SpeciesRouteSeedsShockSiteSmall Interfering RNASmall RNAStressT-LymphocyteTestingTherapeuticTissuesToxic effectUntranslated RNAViralVirusVirus ReplicationWorkantiretroviral therapybasecell killingcrosslinkeffective therapyimmunoregulationin vivoknock-downmutantneuron lossnoveloverexpressionpreventresponsetranscriptome sequencingvirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
! 1!
Summary
The proposal is in response to PA-19-237: Novel RNAs in Virology (including HIV) and Immune Regulation:
Basic Science and Therapeutic Discovery.
HIV-1 (HIV) infects CD4 positive cells causing acquired immunodeficiency syndrome (AIDS). Many forms of
cell death (apoptosis, necrosis, necroptosis, autophagy, pyroptosis, mitotic catastrophe, and others) have been
shown to be involved in virus induced cell loss of directly infected and bystander cells. While current
antiretroviral therapy (ART) now prevents CD4 decline and restores their numbers to nearly normal in most
cases, a major unsolved problem is why some cells survive HIV infection rather than dying, persist with latent
provirus. A fundamental understanding of mechanisms of cell death induction by HIV could provide the means
to kill those cells that constitute a reservoir of reactivatable virus that mandates lifelong ART. Such cells have
so far evaded death from experimental “shock and kill” cure strategies. We have recently discovered a novel
form of cell death that is a combination of almost all of the above-mentioned mechanisms implicated to date in
cell death associated with untreated HIV infection. 6mer Seed Toxicity (6mer Seed Tox) is an RNA interference
(RNAi) based mechanism that kills cells through toxic seeds that target reverse complementary seed matches
in the 3'UTR of a large number of genes that are critical for the survival of all cells. Our recent data suggest
that primary tissues are protected from 6mer Seed Tox by highly expressed miRNAs that do not carry a toxic
seed and block access of the potentially toxic small RNAs to the RNA induced silencing complex (RISC) that
mediates RNAi. Our new preliminary data demonstrate that HIV infection kills cells that lack these protective
miRNAs much more efficiently and it kills cells less efficiently that cannot form a functional RISC to mediate
RNAi. These data suggest that cell death induced by HIV involves the RNAi machinery. The first hypothesis of
this proposal is that HIV kills infected cells by engaging the 6mer Seed Tox mechanism either by triggering the
generation of cell-endogenous toxic sRNAs or by producing virus-encoded toxic sRNAs that enter the RISC.
The second hypothesis is that HIV stresses infected cells in a way that causes downregulation of the miRNA
biogenesis enzyme Dicer decreases maturation of protective miRNAs, sensitizing infected cells to toxic siRNAs
that are generated independently of Dicer. These hypotheses will be studied in two aims: Specific Aim 1:
Determine whether HIV-1 triggers 6mer Seed Tox in infected cells through the production of toxic viral or
cellular sRNAs. Specific Aim 2: Determine whether modulation of protective miRNAs in either direction renders
HIV-1 infected cells more or less susceptible to 6mer Seed Tox. Our work will establish whether HIV kills
infected cells through 6mer seed toxicity. It may pave the way to advance current HIV eradication strategies by
sensitizing cells to induction of 6mer Seed Tox after latency reversal and decreasing neuronal death in HAND.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
-
批准号:10514907
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2022
-
负责人:Marcus E. Peter
-
依托单位:
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
-
批准号:10661817
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2022
-
负责人:Marcus E. Peter
-
依托单位:
Fas protects cancer stem cells from death
-
批准号:8891918
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9313238
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:10224839
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9753713
-
项目类别:
-
资助金额:$88.65万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DICE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9122387
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8187162
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8528496
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7250259
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8698714
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7452329
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7122337
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:6970354
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7623183
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8306703
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
Novel CD95 Signaling Mechanisms
-
批准号:7098097
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
Novel CD95 Signaling Mechanisms
-
批准号:6795872
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
Novel Fas/CD95 Signaling Mechanisms
-
批准号:7688490
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
Novel Fas/CD95 Signaling Mechanisms
-
批准号:8123277
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
海外基金